by University of Alberta Faculty of Medicine & Dentistry A case of pink eye is now reason to be tested for COVID-19, according to University of Alberta researchers. Coughing, fever and difficulty breathing are common symptoms of the illness, but a recent case study involving an Edmonton woman and published in the Canadian Journal of...
Tag: <span>COVID-19</span>
Clear signs of brain injury with severe COVID-19
CREDIT: PHOTO BY JOHAN WINGBORG Certain patients who receive hospital care for coronavirus infection (COVID-19) exhibit clinical and neurochemical signs of brain injury, a University of Gothenburg study shows. In even moderate COVID-19 cases, finding and measuring a blood-based biomarker for brain damage proved to be possible. Some people infected with the coronavirus SARS-CoV-2 get...
Medical groups, health systems expect COVID-19 pinch to last into next year, AMGA says
Medical providers continue to be hit hard financially by COVID-19, as a new survey from the American Medical Group Association found that more than 90% of medical groups and integrated healthcare systems say the pandemic cut revenues by at least 25%. Many have reported revenue losses topping 50%. Moreover, a large percentage of the respondents...
COVID-19 study good news for rheumatic disease patients on immunosuppressants
A European League Against Rheumatism (EULAR) database containing information on the effects of COVID-19 on patients with rheumatic and musculoskeletal diseases has given some reassurance to patients taking immunosuppressants. The drugs studied by the team include anti-malarial drugs, methotrexate, biological therapies such as TNF-alpha inhibitors, and nonsteroidal anti-inflammatory drugs such as Naproxen. None of them...
Update on stem cells for COVID-19, Surgisphere scandal
The term Regenerative Medicine covers so much biomedical science these days including everything from just about any kind of cell therapy (not just stem cells) to CRISPR gene editing, and with the the COVID-19 pandemic, it seems this umbrella use of the term now includes potential treatment of viral illnesses. It can be hard to...
Case series: Teriflunomide therapy in COVID-19 patients with MS
During the COVID-19 pandemic, patients with multiple sclerosis (MS) and their clinicians have had questions and concerns about whether immunotherapies for MS could influence risk for infection or lead to an unfavorable outcome. In the Journal of Neurology, Rohit Bakshi, MD, a senior neurologist at Brigham and Women’s Hospital, and international co-authors present the cases...
Are Patients Dying ‘From’ COVID or ‘With’ COVID?
George D. Lundberg, MD DISCLOSURES June 05, 2020 Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Death is usually fairly easy to diagnose; cause of death, not so much. In fact, death certificates in the United States and around the world are notoriously wrong. How does this happen? Death certificates are...
Exercise may offer ‘profound’ benefits for Friedreich’s ataxia, research suggests
by Josh Barney, University of Virginia UVA researcher Zhen Yan studies the benefits of exercise. “You will benefit from just about any type of exercise as you age, as long as you’re not at risk of injury,” he said. Credit: Dan Addison, University Communications Atop exercise researcher at the University of Virginia School of Medicine...
COULD TINY ‘DISTRACTING’ RODS SAVE COVID-19 PATIENTS?
White blood cells called neutrophils may be central to the immune system overreaction that can kill COVID-19 patients. New research finds that rod-shaped particles can take them out of circulation. The top cause of death for COVID-19 patients echoes the way the 1918 influenza pandemic killed: their lungs fill with fluid and they essentially drown....
COVID-19 immune response may remain stable for two months after diagnosis
by St. George’s University of London Initial results from an antibody testing study have revealed that COVID-19 antibodies remain stable in the blood of the majority of infected individuals almost two months after diagnosis and possibly longer. However, antibodies were not detectable in everyone exposed to the virus, opening discussions on how best to interpret...